News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 17, 2017

Breast Cancer: Survivorship and Exercise

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of woman.

When Chemotherapy Side Effects Sent Her to the ICU

ByLindsey Gunter

December 16th 2025

"FDA" text.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

December 15th 2025

Image of Debbie.

Accepting That You Are Changed by Cancer

ByDebbie Legault

December 15th 2025

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

Trending on CURE

Navigating the Holidays When Cancer Never Quite Leaves

Key Blood Cancer Advances for Patients From the 2025 ASH Annual Meeting

FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer

‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis

Padcev/Keytruda Combo Extends Survival in Muscle-Invasive Bladder Cancer